Home Overview Press Room Blog Publications For Students about us
Search

Sequencing & Genomics : Displaying 11-20 of 1002


2014 in Biomedicine: Rewriting DNA, Decoding the Brain, and a GMO Paradoxby Antonio RegaladoMIT Technology ReviewDecember 30th, 2014From genetically modified foods to gene therapy, 2014 was a big year for rewriting biology.
Every Patient a Subject: When personalized medicine, genomic research, and privacy collideby Jennifer J. Kulynych and Hank GreelySlateDecember 30th, 2014Current norms permit a scientist who gets a sample of blood, tissue, or saliva to sequence and use that genome without the donorís consent, or even without her knowledge.
Commercial DNA Testing May Cause Harm, Scientific Studies Show (If You Read Through to the Study Limitations at the End)by Cecile JanssensHuffington PostDecember 22nd, 2014After the FDA urged 23andMe to stop marketing its personal genome test in the US, the world's largest direct-to-consumer genetics company relaunched the test in Canada and the UK.
Biopolitical News of 2014by Pete Shanks, Jessica Cussins & Marcy DarnovskyBiopolitical TimesDecember 19th, 2014This is everything important that happened in biopolitics in 2014 (or close to it).
Cell Free DNA Screening is not a Simple Blood TestSociety for Maternal Fetal MedicineDecember 18th, 2014By its very nature, a screening test does not tell with 100% certainty whether or not a fetus will be affected by a given disorder.
Top Biopolitical Times Posts of 2014by Jessica Cussins & Pete ShanksBiopolitical TimesDecember 18th, 2014In 2014, CGS staffers and contributors posted 107 blogs in Biopolitical Times. These are twelve of our favorites.
How Exercise Changes Our DNAby Gretchen ReynoldsThe New York TimesDecember 17th, 2014The human genome is astonishingly complex and dynamic, with genes constantly turning on or off, depending on what biochemical signals they receive from the body.
Geneticists Begin Tests of an Internet for DNAby Antonio RegaladoMIT Technology ReviewDecember 17th, 2014Scientists are starting to open their DNA databases online, creating a network that could pave the way for gene analysis at a new scale.
Myriad Loses Appeals Court Bid to Block Breast Cancer Testsby Susan DeckerBloomberg BusinessweekDecember 17th, 2014Myriad Genetics canít block competitorsí DNA tests to determine risk for breast and ovarian cancer after a US appeals court said three patents on the tests never should have been issued.
Prenatal Tests: Oversold and Misunderstoodby George Estreich, Biopolitical Times guest contributorDecember 16th, 2014A scathing investigative report on the accuracy of noninvasive prenatal testing is likely to shift the terms of this important conversation.
Displaying 11-20 of 1002  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760